Barone, Eugenio
 Distribuzione geografica
Continente #
NA - Nord America 906
EU - Europa 802
AS - Asia 222
OC - Oceania 2
SA - Sud America 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.936
Nazione #
US - Stati Uniti d'America 902
DE - Germania 233
UA - Ucraina 169
SE - Svezia 164
CN - Cina 160
FR - Francia 60
IE - Irlanda 54
IT - Italia 43
FI - Finlandia 30
SG - Singapore 25
GB - Regno Unito 18
IN - India 16
JP - Giappone 11
RU - Federazione Russa 10
TR - Turchia 7
PL - Polonia 6
ES - Italia 3
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
CA - Canada 2
CH - Svizzera 2
HK - Hong Kong 2
MX - Messico 2
NL - Olanda 2
SK - Slovacchia (Repubblica Slovacca) 2
AT - Austria 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
NO - Norvegia 1
PH - Filippine 1
SI - Slovenia 1
Totale 1.936
Città #
Chandler 220
Ashburn 92
Jacksonville 83
San Mateo 70
Dublin 51
Nanjing 40
Marseille 33
Lawrence 28
Wilmington 27
Ann Arbor 23
Boston 23
Nanchang 22
Beijing 21
Woodbridge 18
Dearborn 17
Munich 17
Singapore 14
New York 11
University Park 11
Hebei 10
Milan 10
Moscow 10
Changsha 9
Houston 9
Redwood City 9
Mountain View 8
Shenyang 8
Hangzhou 7
Kunming 7
Philadelphia 7
Rende 7
Seattle 7
Tianjin 7
Boardman 6
Cattolica 6
Delhi 6
Detroit 6
Izmir 6
Norwalk 6
Nürnberg 6
Fairfield 5
Jiaxing 5
Zhengzhou 5
Poznan 4
Pune 4
Rome 4
Redmond 3
Shanghai 3
Tokyo 3
Apice 2
Barcelona 2
Bern 2
Bratislava 2
Brussels 2
Busto Arsizio 2
Canberra 2
Hong Kong 2
Hounslow 2
Indiana 2
Leawood 2
Manchester 2
Mexico 2
Princeton 2
Stockholm 2
Amsterdam 1
Athens 1
Berlin 1
Bremen 1
Cambridge 1
Carbondale 1
Chandigarh 1
Columbus 1
Fremont 1
Groningen 1
Hefei 1
Istanbul 1
Kamampa 1
Kilburn 1
Kraków 1
Lanzhou 1
Ljubljana 1
Los Angeles 1
Manila 1
Marche 1
Menlo Park 1
Oakland 1
Paris 1
Phoenixville 1
Pomezia 1
Provo 1
Putian 1
Stoney Creek 1
Thessaloníki 1
Toronto 1
Trieste 1
Vienna 1
Vila Velha 1
Washington 1
Wenzhou 1
Totale 1.079
Nome #
In vivo protective effect of ferulic acid against noise-induced hearing loss in the guinea-pig 101
Inhibition of lipid peroxidation and protein oxidation by endogenous and exogenous antioxidants in rat brain microsomes in vitro 95
CHARACTERIZATION OF THE S-DENITROSYLATING ACTIVITY OF BILIRUBIN 91
Heme oxygenase-derived carbon monoxide modulates gonadotropin-releasing hormone release in immortalized hypothalamic neurons 84
Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before 78
Natural substances and Alzheimer's disease: From preclinical studies to evidence based medicine 76
Heme oxygenase expression and activity in immortalized hypothalamic neurons GT1-7 74
Biliverdin reductase-A protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment 74
Synthesis, characterization, and anti-inflammatory activity of diclofenac-bound cotton fibers 73
Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease 73
Curcumin and Alzheimer disease: this marriage is not to be performed 70
Oxidative and Nitrosative Modifications of Biliverdin Reductase-A in the Brain of Subjects with Alzheimer Disease and Amnestic Mild Cognitive Impairment 64
Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders 64
Curcumin in clinical practice: myth or reality? 62
Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome 61
Experimental research on nitric oxide and therapy of Alzheimer disease: a challenging bridge 61
Coenzyme Q10 and Cognition in atorvastatin treated dogs 60
Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: A novel mechanism of action 59
Sex differences in brain proteomes of neuron-specific STAT3-null mice after cerebral ischemia/reperfusion 59
Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment 58
Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes 58
Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain 56
Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer disease subjects 55
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease 55
Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-B 53
Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain 49
Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases 49
The heme oxygenase/biliverdin reductase pathway in drug research and development 47
Ferulic acid and its therapeutic potential as a hormetin for age-related diseases 45
Therapeutic use of tea derivatives: all that glitters is not gold 38
Totale 1.942
Categoria #
all - tutte 7.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020257 72 11 7 2 7 19 32 7 22 23 22 33
2020/2021240 4 31 1 36 38 9 37 2 35 3 39 5
2021/2022215 20 31 2 8 12 2 6 39 8 11 25 51
2022/2023560 60 91 38 73 56 69 36 47 69 1 10 10
2023/2024232 13 77 1 35 11 23 14 5 2 8 20 23
Totale 1.942